Petra Baumgaertner

6.2k total citations · 4 hit papers
51 papers, 4.0k citations indexed

About

Petra Baumgaertner is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Petra Baumgaertner has authored 51 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 32 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Petra Baumgaertner's work include Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (24 papers) and T-cell and B-cell Immunology (24 papers). Petra Baumgaertner is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), CAR-T cell therapy research (24 papers) and T-cell and B-cell Immunology (24 papers). Petra Baumgaertner collaborates with scholars based in Switzerland, United States and Belgium. Petra Baumgaertner's co-authors include Daniel E. Speiser, Kaat de Jonge, David Gfeller, Julien Racle, Pedro Romero, Nathalie Rufer, Olivier Michielin, Emanuela Romano, Estelle Devêvre and Christiane Meyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Petra Baumgaertner

51 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data

2017 880 citations Kaat de Jonge, Petra Baumgaertner et al. profile →
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

2011 650 citations Lukas Baitsch, Petra Baumgaertner et al. Journal of Clinical Investigation profile →
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

2015 460 citations Emanuela Romano, Petra Baumgaertner et al. Proceedings of the National Academy of Sciences profile →
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

2013 450 citations Laurène Cagnon, Petra Baumgaertner et al. profile →

Peers

Petra Baumgaertner

IMMUN

ONCOL

PRM

Ainhoa Arina United States

Eric R. Lutz United States

Vaios Karanikas Switzerland

Dongkyoon Kim United States

Daniela Bruni France

Yuru Meng United States

Pia Kvistborg Netherlands

William L. Redmond United States

Yasutoshi Agata Japan

Ainhoa Arina United States

Petra Baumgaertner

2.7k ×1.0

IMMUN

2.3k ×1.0

ONCOL

1.1k ×0.9

486 ×0.9

PRM

363 ×0.7

Citations per year, relative to Petra Baumgaertner Petra Baumgaertner (= 1×) peers Ainhoa Arina

Countries citing papers authored by Petra Baumgaertner

Since Specialization

Citations

This map shows the geographic impact of Petra Baumgaertner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Baumgaertner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Baumgaertner more than expected).

Fields of papers citing papers by Petra Baumgaertner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Baumgaertner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Baumgaertner. The network helps show where Petra Baumgaertner may publish in the future.

Co-authorship network of co-authors of Petra Baumgaertner

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Baumgaertner. A scholar is included among the top collaborators of Petra Baumgaertner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Baumgaertner. Petra Baumgaertner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferretti, Lorenza P., Deena M. Leslie Pedrioli, Phil F. Cheng, et al.. (2023). Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma. Cancer Research. 83(23). 3974–3988. 11 indexed citations

Harari, Alexandre, Kaat de Jonge, Anne‐Christine Thierry, et al.. (2021). A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma. Cancers. 13(22). 5801–5801. 6 indexed citations

Graciotti, Michele, Fabio Marino, HuiSong Pak, et al.. (2020). Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines. Vaccines. 8(2). 271–271. 15 indexed citations

Guillaume, Philippe, S. Picaud, Petra Baumgaertner, et al.. (2018). The C-terminal extension landscape of naturally presented HLA-I ligands. Proceedings of the National Academy of Sciences. 115(20). 5083–5088. 35 indexed citations

Neubert, Natalie J., Laure Tillé, David Barras, et al.. (2017). Broad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma Cells. Cancer Research. 77(7). 1623–1636. 8 indexed citations

Gannon, Philippe O., Petra Baumgaertner, Alexandre Huber, et al.. (2016). Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients. Clinical Cancer Research. 23(13). 3285–3296. 19 indexed citations

Murray, T. J., Silvia A. Fuertes Marraco, Petra Baumgaertner, et al.. (2016). Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients. Frontiers in Immunology. 7. 573–573. 82 indexed citations

Legat, Amandine, Hélène Maby–El Hajjami, Petra Baumgaertner, et al.. (2015). Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial. Clinical Cancer Research. 22(6). 1330–1340. 76 indexed citations

Hebeisen, Michaël, Julien Schmidt, Philippe Guillaume, et al.. (2015). Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR–Ligand Off-Rates Measurements on Living Cells. Cancer Research. 75(10). 1983–1991. 38 indexed citations

10.

Hebeisen, Michaël, Lukas Baitsch, Petra Baumgaertner, et al.. (2013). SHP-1 phosphatase activity counteracts increased T cell receptor affinity. Journal of Clinical Investigation. 123(3). 1044–1056. 99 indexed citations

11.

Zoete, Vincent, Sébastien Viatte, Petra Baumgaertner, et al.. (2013). Prediction of Cross-Recognition of Peptide-HLA A2 by Melan-A-Specific Cytotoxic T Lymphocytes Using Three-Dimensional Quantitative Structure-Activity Relationships. PLoS ONE. 8(7). e65590–e65590. 3 indexed citations

12.

Marraco, Silvia A. Fuertes, Petra Baumgaertner, Amandine Legat, Nathalie Rufer, & Daniel E. Speiser. (2012). A stepwise protocol to coat aAPC beads prevents out-competition of anti-CD3 mAb and consequent experimental artefacts. Journal of Immunological Methods. 385(1-2). 90–95. 12 indexed citations

13.

Baitsch, Lukas, Amandine Legat, Leticia Barba, et al.. (2012). Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization. PLoS ONE. 7(2). e30852–e30852. 141 indexed citations

14.

Baitsch, Lukas, Petra Baumgaertner, Estelle Devêvre, et al.. (2011). Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. Journal of Clinical Investigation. 121(6). 2350–2360. 650 indexed citations breakdown →

15.

Iancu, Emanuela M., Patricia Corthésy, Petra Baumgaertner, et al.. (2009). Clonotype Selection and Composition of Human CD8 T Cells Specific for Persistent Herpes Viruses Varies with Differentiation but Is Stable Over Time. The Journal of Immunology. 183(1). 319–331. 58 indexed citations

16.

Wieckowski, Sébastien, Petra Baumgaertner, Patricia Corthésy, et al.. (2009). Fine Structural Variations of αβTCRs Selected by Vaccination with Natural versus Altered Self-Antigen in Melanoma Patients. The Journal of Immunology. 183(8). 5397–5406. 43 indexed citations

17.

Barbey, Catherine, Petra Baumgaertner, Estelle Devêvre, et al.. (2007). IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells. The Journal of Immunology. 178(6). 3566–3574. 14 indexed citations

18.

Derré, Laurent, Petra Baumgaertner, Estelle Devêvre, et al.. (2007). In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration. The Journal of Immunology. 179(4). 2368–2379. 23 indexed citations

19.

Angelov, Georgi S., Philippe Guillaume, Marek Cebecauer, et al.. (2006). Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity. The Journal of Immunology. 176(6). 3356–3365. 20 indexed citations

20.

Doucey, Marie‐Agnès, Daniel F. Legler, Mustapha Faroudi, et al.. (2003). The β1 and β3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation. Journal of Biological Chemistry. 278(29). 26983–26991. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact